You are here

  • Home
  • Archive
  • Volume 29, Issue Suppl 4
  • EP991 Exceptional response with combined anti-hormone and MEK inhibitor therapy in a patient with hormone receptor-positive ovarian cancer and isolated KRAS alteration. Implications for a precision medicine strategy

Article metrics

Article menu
Download PDFPDF
ePoster
EP991 Exceptional response with combined anti-hormone and MEK inhibitor therapy in a patient with hormone receptor-positive ovarian cancer and isolated KRAS alteration. Implications for a precision medicine strategy

 

Online download statistics by month:

Online download statistics by month: November 2019 to April 2024

AbstractFullPdf
Nov 20193901
Dec 20191400
Jan 20202400
Feb 20205502
Mar 20202200
Apr 20201702
May 20202401
Jun 20202002
Jul 20202400
Aug 20201300
Sep 20201800
Oct 20205201
Nov 20208800
Dec 20202800
Jan 20212400
Feb 20211200
Mar 20211200
Apr 2021600
May 20212100
Oct 20211400
Nov 2021200
Dec 20211200
Jan 20224100
Feb 20221000
Mar 2022800
Apr 20221800
May 20221000
Jun 2022600
Jul 20221400
Aug 20221601
Sep 20221801
Oct 20221400
Nov 20221600
Dec 20221400
Jan 2023400
Feb 2023800
Mar 20231000
Apr 2023600
May 20231000
Jun 2023800
Jul 2023600
Aug 2023600
Sep 2023400
Oct 2023400
Nov 20231200
Dec 2023600
Jan 20241400
Feb 2024400
Mar 20241400
Apr 2024400
Total846011